Page 85 - Demo

83to develop the use of AI in precision radiotherapy. %u201cPrecision radiotherapy has three main goals: to provide the right treatment, to target the right patients, and to apply radiation at the right time.%u201d Meanwhile, in the same department, Dr Alvin Chun-hang MA uses zebrafish as model organisms to determine the clinical features of acute myeloid leukaemia in humans. This is useful for targeted therapy and personalised medicine.The right treatmentPrecision radiotherapy aims to kill cancer cells while avoiding damage to healthy cells. But this is not as simple as it sounds. Accurately determining the volume and shape of a tumour is extremely HITTING THE BULLSEYEProf. Jing CAIAssociate Dean, Faculty of Health and Social Sciences Professor, Department of Health Technology and InformaticsProf. Cai is a Fellow of the American Association of Physicists in Medicine (AAPM). He earned his PhD in Engineering Physics in 2006 and then completed his clinical residency in Medical Physics in 2009 at the University of Virginia, US. He worked at Duke University, US, from 2009 to 2017 as Assistant Professor and then Associate Professor before joining PolyU in 2017. His research interests include medical imaging, radiation therapy, artificial intelligence, and bioinformatics. He serves on the editorial boards of several prestigious journals in relevant fields.Technical AdvisorMedVision LimitedDr Alvin Chun-hang MAAssociate Professor, Department of Health Technology and InformaticsDr Ma obtained his PhD from The University of Hong Kong (HKU) in 2009 and received further post-doctoral training at the Mayo Clinic, Minnesota, US. He returned to HKU in 2013 as Research Assistant Professor before joining PolyU in 2016 as Assistant Professor, and was later promoted to Associate Professor in 2022. His research focuses on the applications of the zebrafish model in translational medicine, from evaluation of diseaserelated genes to development of novel therapeutics. He is also a cofounder of ZeBlast, a biotechnology start-up supported by the incubation programme of the Hong Kong Science and Technology Parks Corporation.Co-founderZeBlast Technology Limited